HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Clinicians seek MOC modifications to maximize benefits, ease burdens
-
- ASH releases new ‘Choosing Wisely’ recommendations
- Cidofovir, imiquimod effective alternatives to surgery for vulval intraepithelial neoplasia
- Pediatric nurses association honors members
- Having your prostate exam in the grocery store … in the produce section Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA grants fast track designation to PRM-151 for myelofibrosis
- FDA grants orphan drug status to Actimab-A for AML in elderly patients
- FDA grants orphan drug status to BGB324 for AML
- FDA issues fast track designation to MM-398 for metastatic pancreatic cancer
-
- FDA warns against laparoscopic power morcellation for hysterectomy, myomectomy
- Branched-chain amino acids linked to future pancreatic cancer diagnosis
- Statin use after colorectal cancer diagnosis improved survival
- Effective implementation of nine-valent HPV vaccination could prevent majority of cervical cancers
- Gabapentin no better than standard therapy for prevention of delayed CINV
- High-dose melphalan plus ASCT significantly extended survival in newly diagnosed myeloma
- Ramucirumab offered no benefit in metastatic HER-2–negative breast cancer
- Addition of bevacizumab to erlotinib improved outcomes in EGFR-mutant NSCLC
-
- GVHD prophylaxis with single-agent cyclophosphamide effective after allogeneic transplant
- KRAS status predicted time to recurrence in resected stage III colon cancer
- Recombinant Factor VIII product increased inhibitor development risk
- Telephone counseling increased cardiomyopathy screenings in childhood cancer survivors
- Vitamin D deficiency linked to prostate cancer
- Axillary radiotherapy reduced morbidity in breast cancer with positive sentinel node
- BRAF V600E mutation increased recurrence risk in papillary thyroid cancer
- Carfilzomib combination highly effective in older patients with myeloma
-
- Primary ADT failed to improve survival in prostate cancer
- Women eligible for breast conservation surgery increasingly choose to undergo mastectomy
- Higher copayments linked to therapy nonadherence, discontinuation among women with breast cancer
- Knowledge of individual risk did not increase colorectal cancer screening adherence
- Adjuvant chemotherapy regimen safe, feasible for stage I nonseminomatous germ cell tumors
- FOLFIRI may be viable first-line regimen for advanced gastric, esophagogastric junction adenocarcinoma
- Male pattern baldness increased risk for aggressive prostate cancer
- Model predicted risk for heart failure in childhood cancer survivors
-
- Novel mutation detected in nearly 20% of colorectal, endometrial cancers
- Postsurgical surveillance sufficient for stage I nonseminoma germ cell cancer
- Prediabetes increases risks for cancers overall by up to 15%
- Radiotherapy for testicular cancer increased risk for subsequent stomach cancer
- Sickle cell trait increased risk for pulmonary embolism
- Switch from imatinib to nilotinib improved outcomes in chronic phase CML
- Thoracic radiotherapy improved outcomes in extensive-stage SCLC
- Ziv-aflibercept plus FOLFIRI extended OS in metastatic colorectal cancer
-
- Improved outcomes in HNSCC may be due to HPV incidence
- ASCO: Offer EGFR, ALK testing to all patients with lung adenocarcinoma
- Factor IX gene therapy safe, effective in severe hemophilia B
- More intensive colonoscopy screening yielded little benefit among Medicare beneficiaries
- Researchers identify factors associated with hypocalcemia after thyroidectomy
- PSA screening reduced prostate cancer death by 21%, yet risks remain
- ASH awards seven Bridge Grant awards
- Cancer researcher receives award
-
- Cancer researcher receives award
- Gynecologic cancer group selects chair
- Heart association honors scientist
- Leukemia expert joins UC Irvine
- Professor appointed to FDA position
- Professor receives excellence award
- Breast cancer mutation model may predict response to endocrine therapy
- CAR T-cell therapy shows significant benefit in pediatric ALL
-
- Luspatercept increased hemoglobin, decreased transfusion requirement in beta-thalassemia
- Daratumumab safely added to combination regimens for multiple myeloma
- Elderly patients with early-stage breast cancer derived no survival benefit from capecitabine monotherapy
- PD-L1 and MEK inhibition may be synergistic in triple-negative breast cancer
- Repeat exam of right colon with retroflexed, forward views achieved comparable adenoma detection
- SAR650984 shows promise in relapsed, refractory multiple myeloma
- Stromal TILs relevant to chemotherapy benefit in early-stage, HER-2–positive breast cancer
- CD146 may serve as novel target to treat gastrointestinal GVHD
-
- L-glutamine reduced painful crises, hospitalizations in sickle cell disease
- Pembrolizumab induced durable responses in metastatic triple-negative breast cancer
- Hematopoietic clone tracking may help guide therapies for malignancies
- Nab-paclitaxel demonstrated superiority over paclitaxel in early breast cancer
- Carboplatin improved outcomes in patients with BRCA1/2-mutated metastatic breast cancer